Atul Dandekar, CSBO of Maze Therapeutics MAZE, has filed 0 purchases and 12 sales on the open market. Over the past 12 months that comes to a net sale of $4.2M. The latest trade was on 05/29.

AD

AD

Atul Dandekar

Csbo

Company

Maze Therapeutics MAZE

First filing

25/09/24

Trades

33 trades

Buys / sales

0 / 12

12-month net buying

−$4.2M

Last trade

05/29

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Maze TherapeuticsMAZE	Open-market sale10b5-1 plan	05/29	06/02	7,500 sh	$26.34	$197,550	−23.2%
Maze TherapeuticsMAZE	Open-market sale10b5-1 plan	04/29	05/01	7,500 sh	$25.37	$190,275	−41.7%
Maze TherapeuticsMAZE	Open-market sale10b5-1 plan	03/30	04/01	7,500 sh2 trades	$29.34avg.	$220,050.4	−41.7%
Maze TherapeuticsMAZE	Open-market sale10b5-1 plan	02/27	03/03	7,500 sh2 trades	$45.43avg.	$340,693.99	−41.7%
Maze TherapeuticsMAZE	Open-market sale10b5-1 plan	01/29	02/02	7,500 sh3 trades	$44.26avg.	$331,984	−41.7%
Maze TherapeuticsMAZE	Open-market sale10b5-1 plan	25/12/29–25/12/30	25/12/31	72,500 sh3 trades	$40.56avg.	$2,940,701.7	−87.3%